Thursday, February 06, 2025 10:55:40 PM
Norisk, I realize that this poster has been super critical of NWBO
management and had claimed without evidence that after approval
the company was going to be bought and also underestimated the
considerable strides accomplished with the EDEN vaccine manufacturing
system.
However, I don't remember the poster bashing the science or stating that
DCVax-L will never be approved. Right now I would like to get some information
as to how the poster concluded that the MHRA decision (hopefully approval) will be
forthcoming at the earliest during March because the inspections were not completed
before the end of January and we therefore have to wait till the end of February for the
second and final CHM review.
management and had claimed without evidence that after approval
the company was going to be bought and also underestimated the
considerable strides accomplished with the EDEN vaccine manufacturing
system.
However, I don't remember the poster bashing the science or stating that
DCVax-L will never be approved. Right now I would like to get some information
as to how the poster concluded that the MHRA decision (hopefully approval) will be
forthcoming at the earliest during March because the inspections were not completed
before the end of January and we therefore have to wait till the end of February for the
second and final CHM review.
Bullish
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
